Drug Genius | Prescription Drug Information: Side Effects, Dosage & Interactions

Global Hydroxychloroquine Market is estimated to be US$ 2.7 Billion by 2029 with a CAGR of 5.3% during the Forecast Period - PMI

CytoDyn Reached Its Enrollment Target for Phase 2 COVID-19 Trial for Mild to Moderate Indication – Primary End Point Announcement Is Next

Jun 11, 2020

RedHill Biopharma Submits COVID-19 Clinical Trial Application for Phase 2/3 Study with Opaganib

Jun 10, 2020

Drs. Pourhassan and Kelly of CytoDyn to Hold Conference Call to Provide Updates on COVID-19 Phase 2 and 3 Trials, NASH, BLA for HIV and Manufacturing of Leronlimab in 2020-2021

Jun 09, 2020

Novavax President of R&D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital

Jun 08, 2020

RedHill Biopharma to Provide Update on its COVID-19 and other Development Programs at MedInvest Virtual Infectious Diseases and Immunology Conference

Jun 08, 2020

CytoDyn Receives BLA Acknowledgment Letter From the FDA

Jun 08, 2020

Medication

Victoza - Uses, Side Effects, Dosage & Interactions

Generic Name: Liraglutide Brands: Victoza, Victoza 3-Pak, Victoza 2-Pak, Saxenda Class: Antidiabetics, Glucagon-like Peptide-1 Agonists Availability: Prescription only Molecular Formula:…

View Post

Medication

Valacyclovir - Uses, Side Effects, Dosage & Interactions

Generic Name: Valacyclovir, valaciclovir, valacyclovir hydrochloride Brands: Valtrex Class: Antiviral…

Medication

Otezla - Uses, Side Effects, Dosage & Interactions

Generic Name: apremilast Brands: Otezla Class: immunosuppressant, phosphodiesterase 4 (PDE4) inhibitor…

Medication

Rexulti - Uses, Side Effects, Dosage & Interactions

Generic Name: Brexpiprazole Brands: Rexulti Class: Atypical antipsychotics Availability: Prescription Molecular…

Latest News

News

Pancreatic & Biliary Stents Market Model 2015-2030 (COVID-19 Impact) - ResearchAndMarkets.com

Aug 11, 2020

News

$759M OTC Braces & Supports Market by Product, Application, Distribution and Region - Global Forecast to 2025 - ResearchAndMarkets.com

Aug 11, 2020

News

Moderna, AstraZeneca-Oxford Lead the Race for a COVID-19 Vaccine, but Public Availability Will Take Nearly a Year, and Return to Normalcy Even Longer, Say US Physicians in InCrowd Data

Aug 11, 2020

News

Bicycle Therapeutics Appoints Dr. Dominic Smethurst as Chief Medical Officer

Aug 11, 2020

News

CheckMate -577, a Phase 3 Trial Evaluating Opdivo (nivolumab) as Adjuvant Therapy for Patients with Resected Esophageal or Gastroesophageal Junction Cancer, Meets Primary Endpoint of Disease-Free Survival

Aug 11, 2020

News

CheckMate -649, a Phase 3 Trial Evaluating Opdivo (nivolumab) Plus Chemotherapy vs. Chemotherapy, Meets Primary Endpoints Demonstrating Superior Overall Survival and Progression-Free Survival in First-Line Treatment of Gastric and Esophageal Cancers

Aug 11, 2020

Global Hydroxychloroquine Market is estimated to be US$ 2.7 Billion by 2029 with a CAGR of 5.3% during the Forecast Period - PMI

Polydex Pharmaceuticals Issues First Quarter Financial Results

Phathom Pharmaceuticals Provides Clinical Trial Status Update

PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service